Акне и постакне
1. Аленичев А.Ю., Шарыпова И.В., Эрнандес Е.И. PRP-терапия в дерматологии и эстетической медицине // Новая косметология. Инъекционные методы в косметологии / под общ. ред. Е.И. Эрнандес. 2-е изд., перераб. и доп. Учебное пособие для врачей по специальности «Косметология». Москва : Косметика и медицина, 2018. С. 430–465.
2. Аравийская Е.Р., Соколовский. Е.В. Руководство по дермато-косметологии. Санкт-Петербург : ООО «Издательство Фолиант», 2008. 632 с.
3. Голлберг Д.Д. Лазеро- и светолечение. Том 2. Москва : Рид Элсивер, 2010.
4. Деев А.И., Шарова А.А., Брагина И.Ю. Новая косметология. Аппаратная косметология и физиотерапия. Москва : Косметика и медицина, 2014. 552 c.
5. Клинические рекомендации. Акне вульгарные. Российское общество дерматовенерологов и косметологов, 2020. 33 с.
6. Круглова Л.С., Котенко К.В., Корчажкина Н.Б., Турбовская С.Н. Физиотерапия в дерматологии. Москва : ГЭОТАР-Медиа, 2016. 304 с.
7. Круглова Л.С., Стенько А.Г., Шматова А.А. К вопросу коррекции гипертрофических и келоидных рубцовых деформаций // Клиническая дерматология и венерология. 2012. № 6. С. 46–54.
8. Потекаев Н. Н., Круглова Л. С. Лазер в дерматологии и косме-тологии Москва : МДВ, 2012. 280 c.
9. Талыбова А.M., Круглова Л.С., Стенько А.Г. Лазерная терапия в коррекции атрофических рубцов // Физиотерапевт. 2017. № 1. С. 64–70.
10. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб, и доп. Москва : Деловой экспресс, 2016. 768 с.
11. Alikhan A., Sayed C., Alavi A. et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management // J. Am. Acad. Dermatol. 2019. Vol. 81, N 1. P. 76–90.
12. American Academy of Dermatology website. Guideline development process. URL: https://www.aad.org/practice-tools/quality-care/clinical-guidelines/guideline-develop ment-process (Accessed January 4, 2016)
13. Amichai B., Shemer A., Grunwald M.H. Low-dose isotretinoin in the treatment of acne vulgaris // J. Am. Acad. Dermatol. 2006. Vol. 54. P. 644–646.
14. Andrews’ Diseases of the Skin: Clinical Dermatology / Odom R.B., James W.D., Berger T.G. 12th ed. Saunders, 2015. 968 p.
15. Badaoui A., Reygagne P., Cavelier-Balloy B., Pinquier L., Deschamps L., Crickx B. et al. Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature // Br. J. Dermatol. 2016 Feb. Vol. 174, N 2. P. 421–423.
16. Bhate K., Williams H. Epidemiology of acne vulgaris // Br. J. Dermatol. 2013. Vol. 168. P. 474–485.
17. Cho S., Chung B., Choi M., Baek J., Cho H. Evaluation of the clinical efficacy of fractional radiofrequency microneedle treatment in acne scars and large facial pores // Dermatol. Surg. 2012. Vol. 38, N 7. Pt 1. P. 1017–1024.
18. Clark A., Saric S., Sivamani R. Acne scars: how do we grade them? // Am. J. Clin. Dermatol. 2018 Apr. Vol. 19, N 2. P. 139–144.
19. Cugno M., Borghi A., Marzano A. PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment // Am. J. Clin. Dermatol. 2017. Vol. 18, N 4. P. 555–562.
20. Del Rosso J.Q., Thiboutot D., Gallo R. et al. Consensus recom-mendations from the American Acne and Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care // Cutis. 2013. Vol. 92, N 5. P. 234–240.
21. Dessinioti C., Antoniou C., Katsambas A. Acneiform eruptions // Clin. Dermatol. 2014. Vol. 32, N 1. P. 24–34.
22. Dreno B., Araviiskaia E., Berardesca E., Bieber T. The science of dermocosmetics and its role in dermatology // J. Eur. Acad. Dermatol. Venereol. 2014 Nov. Vol. 28, N 11. P. 1409–1417.
23. Dréno B., Khammari A., Orain N., Noray C., Mérial-Kieny C. ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology // Dermatology. 2007. Vol. 214, N 1. P. 46–51.
24. Dréno B., Layton A., Zouboulis C.C., López-Estebaranz J.L., Zalewska-Janowska A., Bagatin E., Zampeli V., Yutskovskaya Y., Harper J. Adult female acne: a new paradigm // J. Eur. Acad. Dermatol. Venereol. 2013 Sep. Vol. 27, N 9. P. 1063–1070.
25. Dreno B., Tan J., Rivier M., Martel P., Bissonnette R. Adapalene 0,1% benzoyl peroxide 2,5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial // JEADV. 2017. Vol. 31. P. 737–742.
26. Eichenfield L. et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne // Pediatrics. 2013. Vol. 131. P. 163–186.
27. El-Rahman R., El-Komy M., Bassiouny D., El-Tobshy S. Subcision versus 100% trichloroacetic acid in the treatment of rolling acne scars // Dermatol. Surg. 2011. Vol. 37, N 5. P. 626–633.
28. Fiedler F., Stangl G., Fiedler E., Taube K. Acne and nutrition: a systematic review // Acta Derm. Venereol. 2017 Jan 4. Vol. 97, N 1. P. 7–9.
29. Firinu D., Garcia-Larsen V., Manconi P.E., Del Giacco S.R. SAPHO syndrome: current developments and approaches to clinical treatment // Curr. Rheumatol. Rep. 2016. Vol. 18, N 6. P. 35.
30. Friedlander S., Eichenfield L., Fowler J., Fried R., Levy M., Webster G. Acne epidemiology and pathophysiology // Semin. Cutan. Med. Surg. 2010. Vol. 29. P. 2–4.
31. Goh C.L., Abad-Casintahan F., Aw D.C., Baba R., Chan L.C. et al. South-East Asia study alliance guidelines on the management of acne vulgaris in South-East Asian patients // J. Dermatol. 2015 Oct. Vol. 42, N 10. P. 945–953.
32. Gollnick H., Graupe K., Zaumseil R. Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies // J. Dtsch. Dermatol. Ges. 2004. Vol. 2. P. 841–847.
33. Gollnick H., Graupe K., Zaumseil R. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne // Eur. J. Dermatol. 2001. Vol. 11. P. 538–544.
34. Goodman G. Treatment of acne scarring // Int. J. Dermatol. 2011. Vol. 50. P. 1179–1194.
35. Grimes P., Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study // Cutis. 2006. Vol. 77. P. 45–50.
36. Guidelines of care for the management of acne vulgaris / Work Group: A.L. Zaenglein, A.L. Pathy, B.J. Schlosser, A. Alikhan, H.E. Baldwin, D.S. Berson // Am. Acad. Dermatol. 2015. DOI: http://dx.doi.org/10.1016/ j.jaad.2015.12.037.5,6
37. Gupta R., Mahajan B., Garg G. Chemical peeling — evaluation of glycolic acid in varying concentrations and time intervals // Cosmetology. 2001. Vol. 67. P. 28–29.
38. Hayash N., Akamatsu H. Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017 // J. Dermatol. 2018. Vol. 11–12. P. 16.
39. Holzmann R., Shakery K. Postadolescent acne in females // Skin Pharmacol. Physiol. 2014. Vol. 27, suppl. 1. P. 3–8.
40. Iftikha U., Choudhry N. Serum levels of androgens in acne & their role in acne severity // Pak. J. Med. Sci. 2019 Jan-Feb. P. 1–5.
41. Jacob C., Dover J., Kaminer M. Acne scarring: a classification system and review of treatment options // J. Am. Acad. Dermatol. 2001. Vol. 45. P. 109–117.
42. Jemec G., Jemec B. Acne: treatment of scars // Clin. Dermatol. 2004. Vol. 22. P. 434–438.
43. Jović A., Marinović B., Kostović K., Čeović R., Basta-Juzbašić A., Bukvić Mokos Z. The Impact of pyschological stress on acne // Acta Dermatovenerol/ Croat. 2017 Jul. Vol. 25, N 2. P. 1133–1141.
44. Kang S., Amagai M., Bruckner A., Enk A., Margolis D., McMichael A., Orringer J. Fitzpatrick’s Dermatology. 9th ed. New York : McGraw-Hill, 2019. P. 621–648, 1448–1458, 1524–153].
45. Khunger N., Bhardwaj D., Khunger M. Evaluation of CROSS technique with 100% TCA in the management of ice pick acne scars in darker skin types // J. Cosmet. Dermatol. 2011. Vol. 10, N 1. P. 51–57.
46. Kircik L.H. Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications // J. Drugs Dermatol. 2010. Vol. 9, N 11. P. 1407–1411.
47. Krunic A., Ciurea A., Scheman A. et al. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone // J. Am. Acad. Dermatol. 2008. Vol. 58. P. 60–62.
48. Linjawi A., Tork E., Shaibah M. Genetic association of the COL1A1 gene promoter –1997 G/T (rs1107946) and Sp1 +1245 G/T (rs1800012) polymorphisms and keloid scars in a Jeddah population // Turk. J. Med. Sci. 2016. Vol. 46, N 2. P. 414–423.
49. Ljubojevic S., Pasic A., Lipozencic J., Skerlev M. Perifolliculitis capitis abscedens et suffodiens // J. Eur. Acad. Dermatol. Venereol. 2005. Vol. 19. P. 719–721.
50. Lynde C., Kraft J., Lynde C. Topical treatments for melasma and postinflammatory hyperpigmentation // Skin Therapy Lett. 2006. Vol. 11. P. 1–6.
51. Maibach H. Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology // Cutis. 1991. Vol. 48, N 5. P. 411–417.
52. Manuskiatti W., Iamphonrat T., Wanitphakdeedecha R., Eimpunth S. Comparison of fractional erbium-doped yttrium aluminum garnet and carbon dioxide lasers in resurfacing of atrophic acne scars in Asians // Dermatol. Surg. 2013. Vol. 39, N 1. Pt 1. P. 111–20.
53. Marson J., Baldwin H. New concepts, concerns, and creations in acne // Dermatol. Clin. 2019 Jan. Vol. 37, N 1. P. 1–9.
54. Mastroianni A., Cota C., Ardigò M., Berardesca E. Erosive pustular dermatosis of the scalp: a case report and review of the literature // Dermatology. 2005. Vol. 211. P. 273–276.
55. Matard B., Donay J.L., Resche-Rigon M. et al. Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota [published online ahead of print, 2019 Mar 25] // Exp. Dermatol. 2019. DOI: https://doi.org/10.1111/exd.13916
56. Mihić L., Tomas D., Situm M., Krolo I., Sebetić K., Sjerobabski-Masnec I., Barišić F. Perifolliculitis capitis abscedens et suffodiens in a caucasian: diagnostic and therapeutic challenge // Acta Dermatovenerol. Croat. 2011. Vol. 19, N 2. P. 98–102.
57. Mwanthi M., Zaenglein A. Update in the management of acne in adolescence // Curr. Opin. Pediatr. 2018 Aug. Vol. 30, N 4. P. 492–498.
58. Nast A., Dréno B., Bettoli V., Bukvic Mokos Z. et al. European evidence-based (S3) guideline for the treatment of acne — update 2016 — short version // J. Eur. Acad. Dermatol. Venereol. 2016 Aug. Vol. 30, N 8. P. 1261–1268.
59. Nouri K., Vidulich K., Rivas M. Lasers for scars: a review // J. Cosmet. Dermatol. 2006. Vol. 5, N 1. P. 14–22.
60. O’Neill A., Gallo R. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris // Microbiome. 2018. Vol. 6. P. 177. DOI: https://doi.org/10.1186/s40168-018-0558-5
61. Omi T., Numano K. The role of the CO(2) laser and fractional CO (2) laser in dermatology // Laser Ther. 2014. Vol. 23, N 1. P. 49–60.
62. Oon H., Wong N., Aw D., Cheong W., Goh C., Tan H. Acne management guidelines by the Dermatological Society of Singapore // J. Clin. Aesthet. Dermatol. 2019 Jul. Vol. 12, N 7. P. 34–50.
63. Pink A., Anzengruber F., Navarini A.A. Acne and hidradenitis suppurativa // Br. J. Dermatol. 2018 Mar. Vol. 178, N 3. P. 619–631.
64. Rambhia P., Conic R., Murad A., Atanaskova-Mesinkovska N., Piliang M., Bergfeld W. Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis // J. Am. Acad. Dermatol. 2019. Vol. 80, N 3. P. 794–801.
65. Rănişteanu D., Molodoi A., Ciobanu D., Bădescu A., Stoica L., Brănişteanu D., Ţolea I. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp // Rom. J. Morphol. Embryol. 2009. Vol. 50, N 4. P. 719–724.
66. Rocha M., Bagatin E. Skin barrier and microbiome in acne // Arch. Dermatol. Res. 2018 Apr. Vol. 310, N 3. P. 181–185.
67. Sadick N., Cardona A. Laser treatment for facial acne scars: A review // J. Cosmet. Laser Ther. 2018 Nov-Dec. Vol. 20, N 7-8. P. 424–435.
68. Scheinfeld N. Dissecting cellulitis (perifolliculitis capitis abscedens et suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa // Dermatol. Online J. 2014 May. Vol. 20, N 5. Article ID 22692.
69. Scholz C., Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. // Int. J. Syst. Evol. Microbiol. 2016. Vol. 66. P. 4422–4432.
70. Scrimali L., Lomeo G., Nolfo C., Pompili G., Tamburino S., Catalani A. et al. Treatment of hypertrophic scars and keloids with a fractional CO2 laser: a personal experience // J. Cosmet. Laser Ther. 2010. Vol. 12, N 5. P. 218–212.
71. Soliman Y., Horowitz R., Hashim P., Nia J., Farberg A., Goldenberg G. Update on acne scar treatment // Cutis. 2018 Jul. Vol. 102, N 1. P. 21, 25, 47, 48.
72. Stessuk T., Puzzi M., Chaim E., Alves P., de Paula E., Forte A., Izumizawa J.M., Oliveira C.C., Frei F., Ribeiro-Paes J.T. Platelet-rich plasma (PRP) and adipose-derived mesenchymal stem cells: stimulatory effects on proliferation and migration of fibroblasts and keratinocytes in vitro // Arch. Dermatol. Res. 2016. Vol. 308, N 7. P. 511–520.
73. Syed T., Ul Abideen Asad Z., Salem G., Garg K., Rubin E., Agudelo N. Dissecting cellulitis of the scalp: a rare dermatological manifestation of Crohn’s disease // ACG Case Rep J. 2018. Vol. 5. P. e8. Published 2018 Jan 31.
74. Tan J., Tang J., Fung K. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk // J. Cutan. Med. Surg. 2010. Vol. 14. P. 156–160.
75. Tan J., Thiboutot D., Gollnick H., Kang S., Layton A., Leyden J., Torres V. Guillemo J., Dreno B. Development of an atrophic acne scar risk assessment tool // JEADV. 2017. Vol. 31, N 9. P. 1547–1554.
76. Thiboutot D., Dreno B., Abanmi A., Alexis A., Araviiskaia E. et al. Practical management of acne for clinicians: an international consensus from Global Alliance to improve outcomes in acne // J. Am. Acad. Dermatol. 2018 Feb. Vol. 78, N 2. Suppl. 1. P. S1–S23.
77. Thiboutot D., Shalita A., Yamauchi P. et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study // Arch. Dermatol. 2006. Vol. 142, N 5. P. 597–602.
78. Trivedi M., Bosanac S., Sivamani R., Larsen L. Emerging therapies for acne vulgaris // Am. J. Clin. Dermatol. 2018 Aug. Vol. 19, N 4. P. 505–516.
79. Uibu M. Combining RF-microneedling and superficial RF resurfacing // Prime. 2012. Vol. 2. P. 50–55.
80. Vinkel C., Thomsen S.F. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne // Int. J. Dermatol. 2017. Vol. 56, N 8. P. 811–818.
81. Wang L., Gu Z., Gao C. Platelet-rich plasma for treating acute wounds: a meta-analysis // Zhonghua Yi Xue Za Zhi. 2014. Vol. 94, N 28. P. 2169–2174.
82. Webster G., Graber E. Antibiotic treatment for acne vulgaris // Semin. Cutan. Med. Surg. 2008. Vol. 27, N 3. P. 183–187.
83. Xu H., Li H. Acne, the skin microbiome, and antibiotic treatment // Am. J. Clin. Dermatol. 2019 Jun. Vol. 20, N 3. P. 335–344.
84. Zaenglein A., Pathy A., Schlosser B., Alikhan A., Baldwin H. et al. Guidelines of care for the management of acne vulgaris // J. Am. Acad. Dermatol. 2016 May. Vol. 74, N 5. P. 945–973.
85. Zayed A., Sobhi R., El Aguizy R., Sabry D., Mahmoud S. Sequential peeling as a monotherapy for treatment of milder forms of acne vulgaris // J. Cosmet. Dermatol. 2020. Vol. 19, N 6. P. 1381–1387. Epub 2019 Sep 23.
86. Zouboulis C., Desai N., Emtestam L. et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa // J. Eur. Acad. Dermatol. Venereol. 2015. Vol. 29, N 4. P. 619–644.